LINCOCIN

LOE Approaching

lincomycin hydrochloride

Pfizer
NDAINJECTIONINJECTABLE
Approved
Dec 1964
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

Mechanism of Action Lincomycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the bacterial ribosome. Lincomycin is predominantly bacteriostatic in vitro .

Indications (5)

the treatment of serious infections due to susceptible strains of streptococcipneumococcistaphylococcithe treatment of minor bacterial infectionsviral infections

Clinical Trials (1)

NCT01058824Phase 1Completed

Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule

Started Apr 2009
36 enrolled
Bacterial Infections
Company
Pfizer
Pfizer
NEW YORK, NY
577 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers